Article
From the Genetics of Ankylosing Spondylitis to New Biology and Drug Target Discovery.
Frontiers in immunology - 1 Jan 2021
Nancy Zaarour, Yan Li, Hui Shi, Paul Bowness, Liye Chen
Abstract excerpt
Genome-wide association studies (GWAS) have identified 113 single nucleotide polymorphisms (SNPs) affecting the risk of developing ankylosing spondylitis (AS), and an on-going GWAS study will likely identify 100+ new risk loci. The translation of genetic findings to novel disease biology and treatments has been difficult due to the following challenges: (1) difficulties in determining the causal genes regulated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
